Not applicableStudy completedNCT04755465What this trial is testingEffects of NMES and Exercise in Hematological CancerWho this might be right forHematologic MalignancyMuscle Weakness Acibadem University 31
Testing effectiveness (Phase 2)Study completedNCT00445900What this trial is testingThalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid MetaplasiaWho this might be right forChronic Myeloproliferative DisordersSecondary Myelofibrosis Mayo Clinic 22
Testing effectiveness (Phase 2)Ended earlyNCT03769532What this trial is testingMRD-guided Treatment in NPM1mut AML PatientsWho this might be right forAcute Myeloid Leukemia Technische Universität Dresden 26
Not applicableEnrolling By InvitationNCT05600933What this trial is testingProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor MicroenvironmentWho this might be right forSolid TumorsHematologic MalignancyGastrointestinal Cancer+5 more National Cancer Institute (NCI) 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03642626What this trial is testingMT2017-45: CAR-T Cell Therapy for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaLarge B-cell Lymphoma Masonic Cancer Center, University of Minnesota 150
Early research (Phase 1)Study completedNCT00720785What this trial is testingNatural Killer Cells and Bortezomib to Treat CancerWho this might be right forChronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableNot Yet RecruitingNCT07634263What this trial is testingWhy Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods StudyWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaMultiple Myeloma ProgressionMultiple Myeloma Refractory Odense University Hospital 50
Early research (Phase 1)Study completedNCT00824135What this trial is testingHaploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic MalignanciesWho this might be right forHematologic Malignancies St. Jude Children's Research Hospital 34
Not applicableStudy completedNCT04014764What this trial is testingCollect and Assess Tissue Samples From Subjects With Hematologic MalignancyWho this might be right forAcute Myelogenous LeukemiaMultiple MyelomaMyelodysplastic Syndromes+4 more Notable Labs 119
Testing effectiveness (Phase 2)Study completedNCT00145626What this trial is testingHLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplasia+2 more St. Jude Children's Research Hospital 40
Early research (Phase 1)Active Not RecruitingNCT04013685What this trial is testingPrecision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+3 more Orca Biosystems, Inc. 155
Early research (Phase 1)Active Not RecruitingNCT03531736What this trial is testingT Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic AnemiaWho this might be right forMyeloid Diseases Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00146614What this trial is testingTacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell TransplantationWho this might be right forGraft Versus Host DiseaseHematologic Malignancies Dana-Farber Cancer Institute 105
Not applicableStudy completedNCT04965649What this trial is testingIs There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.Who this might be right forLeukemiaMyelogenous LeukemiaChronic Leukemia+1 more Centre Hospitalier Universitaire de Nīmes 30
Not applicableStudy completedNCT04760184What this trial is testingImpact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in SwedenWho this might be right forCovid19Myeloma MultipleMalignant Lymphoma+2 more Uppsala University 20
Not applicableStudy completedNCT03399149What this trial is testingSystematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic FailureWho this might be right forRespiratory InsufficiencyHematologic Malignancy University Hospital, Grenoble 221
Early research (Phase 1)UnknownNCT04709458What this trial is testingSafety and Early Efficacy Study of TBX-2400 in Patients With AML or MyelofibrosisWho this might be right forMyelofibrosisAcute Myelogenous Leukemia Taiga Biotechnologies, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT00555048What this trial is testingAlemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Temporarily pausedNCT06661915What this trial is testingStudy of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)Who this might be right forAccelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative NeoplasmEssential Thrombocythemia+5 more National Cancer Institute (NCI) 62
Early research (Phase 1)Looking for participantsNCT07379125What this trial is testingTherapeutic RSK1 Targeting in MyelofibrosisWho this might be right forMyelofibrosis Washington University School of Medicine 18